Suppr超能文献

替代性基质:细胞外基质蛋白在发育、稳态和肿瘤进展中的可变剪接。

The alternative matrisome: Alternative splicing of ECM proteins in development, homeostasis and tumor progression.

机构信息

Université Côte d'Azur, CNRS, INSERM, Institut de Biologie Valrose (iBV), Nice 06108, France.

Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu FI-90014, Finland; Faculty of Medicine, Research Unit of Biomedicine, University of Oulu, Oulu FI-90014, Finland; Foundation for the Finnish Cancer Institute, Tukholmankatu 8, Helsinki, Finland.

出版信息

Matrix Biol. 2022 Aug;111:26-52. doi: 10.1016/j.matbio.2022.05.003. Epub 2022 May 7.

Abstract

The extracellular matrix (ECM) is a fundamental component of the tissue of multicellular organisms that is comprised of an intricate network of multidomain proteins and associated factors, collectively known as the matrisome. The ECM creates a biophysical environment that regulates essential cellular processes such as adhesion, proliferation and migration and impacts cell fate decisions. The composition of the ECM varies across organs, developmental stages and diseases. Interestingly, most ECM genes generate transcripts that undergo extensive alternative splicing events, producing multiple protein variants from one gene thus enhancing ECM complexity and impacting matrix architecture. Extensive studies over the past several decades have linked ECM remodeling and expression of alternatively spliced ECM isoforms to cancer, and reprogramming of the alternative splicing patterns in cells has recently been proposed as a new hallmark of tumor progression. Indeed, tumor-associated alternative splicing occurs in both malignant and non-malignant cells of the tumor environment and growing evidence suggests that expression of specific ECM splicing variants could be a key step for stromal activation. In this review, we present a general overview of alternative splicing mechanisms, featuring examples of ECM components. The importance of ECM variant expression during essential physiological processes, such as tissue organization and embryonic development is discussed as well as the dysregulation of alternative splicing in cancer. The overall aim of this review is to address the complexity of the ECM by highlighting the importance of the yet-to-be-fully-characterized "alternative" matrisome in physiological and pathological states such as cancer.

摘要

细胞外基质 (ECM) 是多细胞生物组织的基本组成部分,由多结构域蛋白和相关因子组成的复杂网络组成,统称为基质组。ECM 创造了一个生物物理环境,调节细胞的粘附、增殖和迁移等基本过程,并影响细胞命运的决定。ECM 的组成在不同的器官、发育阶段和疾病中有所不同。有趣的是,大多数 ECM 基因产生的转录本经历广泛的选择性剪接事件,从而从一个基因产生多种蛋白质变体,从而增加 ECM 的复杂性并影响基质结构。过去几十年的广泛研究将 ECM 重塑和选择性剪接 ECM 异构体的表达与癌症联系起来,最近提出细胞中选择性剪接模式的重编程是肿瘤进展的一个新标志。事实上,肿瘤相关的选择性剪接发生在肿瘤环境中的恶性和非恶性细胞中,越来越多的证据表明,特定 ECM 剪接变体的表达可能是基质激活的关键步骤。在这篇综述中,我们介绍了选择性剪接机制的概述,其中包括 ECM 成分的例子。讨论了 ECM 变体在组织形成和胚胎发育等重要生理过程中的表达的重要性,以及在癌症中选择性剪接的失调。本综述的总体目标是通过突出尚未完全表征的“替代性”基质组在生理和病理状态(如癌症)中的重要性来解决 ECM 的复杂性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验